Vertex Pharmaceuticals will not advance clinical trials of a treatment for Type 1 diabetes after efficacy data failed to support further clinical advancement.

Zimislecel, Vertex’s investigational fully differentiated islet cell therapy with standard immunosuppression, is in the Phase 3 portion of the ...

Vertex Pharmaceuticals (VRTX) closed the latest trading day at $492.69, indicating a -1.96% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Are stock shafts or aftermarket shafts best suited for your game? Here is what to consider when making the decision.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

They eliminate the need to carry around bulky conversion charts or rely on manual calculations. Instead, you can rely on the app to provide up-to-date exchange rates, ensuring that you are always ...

Andrea Bocelli Last week Weeks at no. 1 Weeks on chart Sugar/Decca/VLG Week of March 29, 2025 click to see more Sugar/Decca/VLG BBC/Republic ...

Doechii Last week Weeks at no. 1 Weeks on chart Top Dawg/Capitol/ICLG Greatest gainer this week Gains In Performance Week of March 29, 2025 click to see more ...